Ceftizoxime sodium(CAS: 68401-82-1)

Ceftizoxime sodium (CAS: 68401-82-1) is a third-generation cephalosporin antibiotic used to treat bacterial infections. Its chemical formula is C16H16N5O7S2Na, with a molecular weight of 473.5 g/mol. It is highly soluble in water, making it suitable for injectable formulations. The compound exhibits broad-spectrum activity against Gram-negative bacteria and is structurally characterized by its 3-ethoxy-1-(4-hydroxyphenyl)propyl side chain, enhancing its efficacy and stability in pharmaceutical applications.

Ceftizoxime sodium (CAS: 68401-82-1) is primarily used in pharmaceuticals to combat severe bacterial infections, including respiratory tract, urinary tract, and skin infections. It targets Gram-negative pathogens such as *E. coli* and *K. pneumoniae*. In veterinary medicine, it is employed for livestock treatments. Its broad-spectrum activity and stability make it a key component in antibiotic therapies, particularly in cases resistant to other medications. Additionally, it is used in research for studying antimicrobial mechanisms.

Ceftizoxime sodium (CAS: 68401-82-1) is considered safe when administered as directed, but it may cause side effects such as allergic reactions, gastrointestinal discomfort, or superinfections. Handling precautions include wearing gloves and avoiding contact with eyes. It is approved by regulatory bodies like the FDA for medical use, and safety standards emphasize proper disposal to prevent environmental contamination. Always consult healthcare professionals for appropriate usage and risk assessment.

Ceftizoxime sodium (CAS: 68401-82-1) should be stored in a cool, dry place at 2-8°C (36-46°F) to maintain stability and potency. Protect from light and moisture by using airtight containers. Avoid exposure to extreme temperatures or humidity to prevent degradation. The compound has a shelf life of up to 24 months when unopened and properly stored, ensuring long-term efficacy in pharmaceutical and research settings.